Home›Companies›Talus Bioscience

Talus Bioscience, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 12, 2024·Suggest an edit

About Talus Bioscience

Talus Bioscience is a private company based in Seattle, Washington, incorporated in 2020 in Delaware. It has reported $9,423,516 raised in one offering on Form D since August 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 29, 2024Aug 12, 2024$9,423,516of $11.3M target11$856KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Talus Bioscience's Form D filed Aug 12, 2024.

LP
Lindsay Pino
Executive officer and director
MB
Michelle Briscoe
Chief Operating Officer
AF
Alex Federation
Executive officer, director and promoter
JS
J. Strattan
Director

Sources

  1. SECTalus Bioscience, Inc. filing history